Prospective validation of the EASL-EASD algorithm for risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes
About one in five patients with FIB-4≥1.3 had advanced MASLD. The EASL-EASD algorithm supports early detection and referral.
Authors
- Marta Abadía Barnó
- Antonio Olveira (ORCID: https://orcid.org/0000-0002-2991-4688)
- Clara Amiama Roig (ORCID: https://orcid.org/0000-0002-6327-010X)
- Antonio Buño Soto (ORCID: https://orcid.org/0000-0002-8306-889X)
- Laura Guerra (ORCID: https://orcid.org/0000-0002-8478-8522)
- Irene González Díaz (ORCID: https://orcid.org/0000-0003-4014-6939)
- Macarena G. Sanz (ORCID: https://orcid.org/0000-0001-6565-9947)
- Miriam Romero
- Estibaliz Lazaro (ORCID: https://orcid.org/0000-0002-4206-7399)
- Araceli García Sánchez
- Pilar Castillo Grau
- Noemí González
- Mariana Serrés
- C. Ben Amor
Institutions
- Hospital Universitario La Paz (ES)
Publication Details
- Journal
- Revista Española de Enfermedades Digestivas
- Published
- 2025-01-01
- DOI
- https://doi.org/10.17235/reed.2025.11545/2025
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00